What Valsynthese does

Valsynthese SA is a Swiss contract manufacturing organization (CMO) headquartered in Brig, Switzerland, operating as a subsidiary of the privately held SSE Group (Société Suisse des Explosifs), a diversified industrial conglomerate with 700 employees across 9 countries and 130 years of corporate history. Founded in 1983/1984, the company specializes in custom synthesis and contract manufacturing for the chemical and pharmaceutical industries, with a differentiated focus on high energetic and highly hazardous chemistry — a niche capability that few competitors handle. Manufacturing is conducted at ISO and cGMP certified facilities in Brig and Gamsen, producing Advanced Intermediates for Fine Chemicals, Active Pharmaceutical Ingredients (APIs) with DMF registration, and a catalogue of standard intermediates spanning nitrite, nitro, carboxylic acid, anhydride, amino acid, imide, chloroformate, and isocyanate derivatives.

The company's core technology platform combines established hazardous chemistry expertise with innovative flow process capabilities, notably through a co-development partnership with Chemium that enables large-scale Grignard reagent production via continuous flow rather than batch processing. Services cover the full project lifecycle — sourcing, chemical and analytical development, pilot production, commercial production (gram to ton-scale), and registration support — positioning Valsynthese as a full-service provider rather than a toll manufacturer. The product portfolio is split between project-based custom synthesis (primary revenue driver) and catalogue products for distribution across pharmaceutical, fine chemical, electronics, agrochemical, and personal care end markets.

Valsynthese operates a direct enterprise sales motion targeting technical and procurement teams at pharmaceutical and chemical companies, supported by participation in major industry events (CPHI Milan 2024, CPHI Frankfurt 2022), a virtual exhibition platform, webinars, and content marketing. Pricing is project-specific and quote-based; no public pricing exists. The company is privately held with no external investors or public shareholders identified, and financial figures (revenue, profitability) are not publicly disclosed. SSE Group, the parent, has reported eight consecutive years of growth as of mid-2026, suggesting stable expansion at the group level.

Name

Valsynthese

Legal name

VALSYNTHESE SA

Website

https://valsynthese.ch

Company type

Private

Founded year

1984

Operating status

Operating

Headcount range

1,001–5,000 employees

Short description

Valsynthese SA is a Swiss contract manufacturer specializing in custom synthesis of high energetic and hazardous chemical intermediates and pharmaceutical APIs, serving chemical, pharmaceutical, and personal care customers from ISO and cGMP certified facilities in Brig, Switzerland, as a subsidiary of SSE Group.

Ownership category

akta.pro rank

Headquarters

HQ city

Brig

HQ country

Switzerland

HQ region

Europe

Offices2 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Supply Chain, Infrastructure, Technology or R&D, Operations, Marketing or Sales

Revenue model

1. Custom Synthesis Services: Contract manufacturing services for custom synthesis projects for the chemical and pharmaceutical industries. Services range from gram to ton-scale production with full project lifecycle support.
2. Catalogue Products: Standard chemical products sold from inventory including nitrite derivatives, nitro derivatives, carboxylic acid derivatives, anhydride derivatives, amino acid derivatives, imide derivatives, chloroformates, isocyanates, and specialty compounds.
3. Active Pharmaceutical Ingredients (APIs): Manufacturing of pharmaceutical Active Pharmaceutical Ingredients with DMF (Drug Master File) registration capability.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels6 records

Core offering

Valsynthese, part of SSE Group, is a contract manufacturing organization offering custom synthesis and contract manufacturing for the chemical and pharmaceutical industries. Its core capabilities are focused on high energetic and highly hazardous chemistry, producing Advanced Intermediates for Fine Chemicals and Active Pharmaceutical Ingredients with DMF registration in ISO and cGMP certified facilities, with services spanning gram to ton-scale production.

Product overview

Valsynthese SA is a Swiss chemical and pharmaceutical contract manufacturer specializing in custom synthesis and contract manufacturing services. The company operates as part of SSE Group and focuses on high energetic and highly hazardous chemistry. The product portfolio consists of custom manufacturing services (offering the full range from gram to ton-scale synthesis, including sourcing, chemical development, analytical development, pilot production, and commercial production) combined with a comprehensive catalogue of standard chemical intermediates including Nitrite Derivatives, Nitro Derivatives, Carboxylic Acid Derivatives, Anhydride Derivatives (such as BTA and HBTA), Aminoacid Derivatives, Imide Derivatives (including BTI and CHDI), Chloroformates, and Isocyanates. The company manufactures both custom compounds for specific client needs and catalogue products for the pharmaceutical, fine chemicals, electronics, and agrochemical industries, with facilities certified to both ISO and cGMP standards.

Differentiator

Problem solved

Functional benefit

Products and services

• Custom Synthesis Services Full-service custom chemical synthesis for the chemical and pharmaceutical industries, from gram to ton-scale production, including sourcing, chemical development, analytical development, pilot production, and commercial production.
• Contract Manufacturing Services Contract manufacturing for Advanced Intermediates for Fine Chemicals and Pharmaceutical products as well as Active Pharmaceutical Ingredients with DMF registration.
• Nitrite Derivatives Chemical intermediates including iso-Butyl nitrite, Cyclopentyl nitrite, Isopentenyl nitrite, Cyclohexyl nitrite, n-Hexyl nitrite, Cycloheptyl nitrite, n-Heptyl nitrite, Cyclooctyl nitrite, n-Octyl nitrite, Tetrabutylammonium nitrite, Amyl Nitrite, Isoamyl Nitrite, n-Butyl Nitrite, and t-Butyl Nitrite.
• Nitro Derivatives Chemical intermediates including 5-Nitrosalicylaldehyde, Nitroglycerine formulations, p-Nitrophenylpropionitrile, 2-Nitrothiophene, and 2-Ethyl-5-nitroaniline (ENA).
• Carboxylic Acid Derivatives Dicarboxylic acids and derivatives including Malonic acid, Succinic acid, Glutaric acid, Adipic acid, Pimelic acid, Azelaic acid, Sebacic acid, Undecanedioic acid, Fumaric acid, Maleic acid, Bicyclo[2.2.2]oct-7-ene-2,3,5,6-tetracarboxylic acid, Diglycolic acid, Dodecanedioic acid, cyclohexanehexacarboxylic acid, pentasodium hydrogen cyclohexanehexacarboxylate, HBTC, and Suberic acid.
• Anhydride Derivatives Dianhydride compounds including 4,4'-(Hexafluoroisopropylidene)diphthalic anhydride, Bicyclo[2.2.2]oct-7-ene-2,3:5,6-tetracarboxylic dianhydride (BTA), Bicyclooctanetetracarboxylic dianhydride (HBTA), 1,2,3,4,5,6-Cyclohexanehexacarboxylic acid trianhydride (CHHA), and 1,2,4,5-Cyclohexanetetracarboxylic dianhydride (CHDA).
• Amino Acid Derivatives Amino acid derivatives including L-Valine N-carboxyanhydride (L-Val-NCA, CAS 24601-74-9).
• Imide Derivatives Imide derivatives including Bicyclo[2.2.2]oct-7-ene-2,3,5,6-tetracarboxylic diimide (BTI), Bicyclo[2.2.2]octane-2,3,5,6-tetracarboxylic diimide (HBTI), 1,2,4,5-Cyclohexanetetracarboxylic diimide (CHDI), and various N,N'-substituted derivatives for polymer and pharmaceutical applications.
• Chloroformates Alkyl and cycloalkyl chloroformate derivatives including n-Propyl, Isopropyl, Cyclobutyl, n-Butyl, Isobutyl, Cyclopentyl, n-Pentyl, Isopentyl, 2-Methylbutyl, Cyclohexyl, n-Hexyl, Cycloheptyl, n-Heptyl, Cyclooctyl, and n-Octyl chloroformate.
• Isocyanates Isocyanate compounds including 4-Isocyanatobenzoyl chloride (PIBC, CAS 3729-21-3) used as a building block in organic synthesis for ureas, carbamates, amides, and polymer synthesis.
• Active Pharmaceutical Ingredients (APIs) Active Pharmaceutical Ingredients produced with DMF registration capability in cGMP certified manufacturing facilities.

Named customers1 record

Segments3 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

One partnership is on record.

• ChemiumcoreStrategic or Co-development PartnerValsynthese and Chemium collaborated on large-scale Grignard reagents production using flow process technology. This partnership combines Valsynthese's hazardous chemistry manufacturing expertise with Chemium's flow process capabilities, enabling safer and more efficient production of Grignard reagents at commercial scale.

Scale indicators5 records

Direct peers

• Carbogen Amcis: Swiss CDMO specializing in highly potent and hazardous chemistry for pharmaceutical customers, including custom synthesis and API development. Direct competitor in Valsynthese's niche of complex, regulated chemistry.
• Siegfried Holding: Swiss-headquartered pharmaceutical CDMO offering custom synthesis, API manufacturing, and intermediates from gram to commercial scale. Closest comparable to Valsynthese in size, geography, and full-service pharma CMO model.
• WeylChem: Custom synthesis and fine chemicals manufacturer under International Chemical Investors Group serving pharmaceutical, agrochemical, and specialty chemical industries. Similar mid-sized European CDMO business model.
• Bachem: Swiss CDMO focused on peptide and oligonucleotide APIs and complex intermediates. Comparable in size, regulatory positioning, and pharma customer base, though specialized in a different chemistry vertical.
• Saltigo: Custom synthesis subsidiary of Lanxess providing exclusive synthesis and contract manufacturing for agrochemical, pharmaceutical, and specialty chemical customers. Directly comparable custom synthesis business model.

Broad incumbents

• Lonza Group: World's largest pharmaceutical CDMO based in Switzerland, offering custom synthesis, API manufacturing, and complex chemistry at industrial scale. Broader and larger than Valsynthese but operates in the same custom manufacturing category.
• Johnson Matthey: Specialty chemicals company with significant custom synthesis and catalyst operations serving pharmaceutical and chemical customers. Larger and more diversified but competes in custom manufacturing space.
• Boehringer Ingelheim BioXcellence: Large pharmaceutical CDMO providing custom API and intermediates manufacturing with extensive cGMP capabilities. Broader offering but relevant competitor for pharmaceutical custom synthesis customers.

Market position

Strengths5 records

Weaknesses5 records

Key risks5 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/valsynthese
• Xx.com/valsynthese

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Valsynthese